Brief: Baxter Q1 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.31
30/04/2026 12:15
Apr 30 (Reuters) - Baxter Q1 revenue USD 2,701 million vs. IBES estimate USD 2,616 million. Q1 net income USD -15 million outlook FY revenue growth 0-1% outlook FY adjusted EPS USD 1.85-2.05 vs. IBES estimate USD 1.91
Recent news on Baxter International
See all newsS&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Press Digest: British Business - August 20
Brief: Baxter Appoints John Rogers Chief Financial Officer
Brief: Baxter Announces Pricing For Its Upsized Cash Tender Offers